OrganOx Analysis: $238M Raised
What is OrganOx?
OrganOx specializes in normothermic machine perfusion technology to enhance liver transplantation outcomes. Their technology aims to extend organ preservation and improve patient survival rates. The company collaborates with leading research institutions to advance organ preservation methods.
Location
Magdalen Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4GA, United Kingdom
Employees
201-500
Founded
2008
Funding Status
Series D
Product Features & Capabilities
- metra® liver perfusion device
- Product documentation for metra®
- NMP technology for organ preservation
Use Cases
Utilize metra® for liver perfusion during transplantation; Conduct research on organ viability with NMP technology; Support air transport of livers with FDA-approved metra®; Enhance organ preservation for clinical trials; Decrease wait times for liver transplants
HQ Full Address
Magdalen Centre, Robert Robinson Avenue, Oxford, Oxfordshire OX4 4GA, United Kingdom
Other Considerations
Acquired by Terumo Corporation to advance organ transplantation; metra® received FDA approval for air transport; Collaborates with top institutions for organ research
See something that needs updating? Suggest edits to this profile.